Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec 6:10:1469.
doi: 10.3389/fphar.2019.01469. eCollection 2019.

Application and Mechanisms of Triptolide in the Treatment of Inflammatory Diseases-A Review

Affiliations
Review

Application and Mechanisms of Triptolide in the Treatment of Inflammatory Diseases-A Review

Kai Yuan et al. Front Pharmacol. .

Abstract

Bioactive compounds from medicinal plants with anti-inflammatory and immunosuppressive effects have been emerging as important sources of drugs for the treatment of inflammatory disorders. Triptolide, a diterpene triepoxide, is a pharmacologically active compound isolated from Tripterygium wilfordii Hook F (TwHF) that is used as a remedy for inflammatory and autoimmune diseases. As the most promising bioactive compound obtained from TwHF, triptolide has attracted considerable interest recently, especially for its potent anti-inflammatory and immunosuppressive activities. Over the past few years, an increasing number of studies have been published emphasizing the value of triptolide in the treatment of diverse inflammatory disorders. Here, we systematically review the mechanism of action and the therapeutic properties of triptolide in various inflammatory diseases according to different systematic organs, including lupus nephritis, inflammatory bowel disease, asthma, and rheumatoid arthritis with pubmed and Embase. Based on this review, potential research strategies might contribute to the clinical application of triptolide in the future.

Keywords: Embase; anti-inflammation; immunosuppression; inflammatory disorders; pubmed; triptolide.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chemical structure of triptolide.Triptolide has been shown to possess a broad spectrum of anti-inflammatory and immunosuppressive properties in treating various inflammatory disorder models. Based on potent anti-inflammatory biological activities, triptolide has increasingly drawn attention worldwide in recent decades.
Figure 2
Figure 2
Anti-inflammatory effect(s) of triptolide on RA.Triptolide has a broad array of cellular mechanisms and potential therapeutic applications ( Table 1 ).

References

    1. Abraham C., Cho J. H. (2009). Inflammatory bowel disease. N. Engl. J. Med. 361, 2066–2078. 10.1056/NEJMra0804647 - DOI - PMC - PubMed
    1. Bao X., Cui J., Wu Y., Han X., Gao C., Hua Z., et al. (2007). The roles of endogenous reactive oxygen species and nitric oxide in triptolide-induced apoptotic cell death in macrophages. J. Mol. Med. (Berl). 85, 85–98. 10.1007/s00109-006-0113-x - DOI - PubMed
    1. Bartok B., Firestein G. S. (2010). Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol. Rev. 233, 233–255. 10.1111/j.0105-2896.2009.00859.x - DOI - PMC - PubMed
    1. Bataller R., Brenner D. A. (2005). Liver fibrosis. J. Clin. Invest. 115, 209–218. 10.1172/JCI24282 - DOI - PMC - PubMed
    1. Bell G. M., Anderson A. E., Diboll J., Reece R., Eltherington O., Harry R. A., et al. (2017). Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis. Ann. Rheumatol. Dis. 76, 227–234. 10.1136/annrheumdis-2015-208456 - DOI - PMC - PubMed